Highlights Nova Eye Medical Limited

Equities

EYE

AU0000094252

Market Closed - Australian S.E. Other stock markets 07:10:37 13/05/2024 BST			5-day change	1st Jan Change
0.265 ^AUD	+1.92%		+1.92%	+10.42%

03-15	Nova Eye Medical Completes Retail Entitlement Offer	MT
02-22	Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-22	CI
Rights Issue: 1 new share @ 0.21 AUD for 8 existing shares	02-13	FA
Nova Eye Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2023	27/08/23	CI
Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/02/23	CI
Nova Eye Medical Limited Announces New, Additional Clinical Application for 2RT Currently Under Investigation	24/01/23	CI
Nova Eye Medical Limited Completes Initial Recruitment of Investigator Sites	23/10/22	CI
Nova Eye Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2022	26/08/22	CI
Nova Eye Medical Limited Announces the Commencement of the Commercial Roll-Out of its Next Generation Canaloplasty Device, iTrack Advance, in Select Markets in Europe and the Asia Pacific	08/06/22	CI
Nova Eye Medical Limited Announces Regulatory Pathway for AlphaRET 2RT in the USA	02/05/22	CI
Nova Eye Medical Limited Announces Results of a Retrospective Case Series Which Demonstrating the Efficacy and Safety of Canaloplasty	07/10/21	CI
Nova Eye Medical : Closes Unmarketable Parcels Share Sale Facility	03/09/21	MT
Nova Eye Medical : Completes Acquisition of Glaucoma Patents	26/08/21	MT
Nova Eye Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2021	18/08/21	CI
Nova Eye Medical Limited Announces First Patient Enrollment in MAGIC Clinical Trial	29/04/21	CI
Nova Eye Medical Limited Announces Publication of Positive Five-Year Patient Follow-Up Data from Sub-Study Analysis of the Lead Trial in Ophthalmology Retina	04/03/21	CI
Nova Eye Medical Limited Launches New Clinical Trial to Assess Efficacy and Safety of Itracktm in the Treatment of Mild to Moderate Glaucoma	01/03/21	CI
Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2020	24/02/21	CI
Nova Eye Medical Limited Announces Establishment of AlpaRET	25/10/20	CI
Nova Eye Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2020	28/08/20	CI
Nova Eye Medical Limited Reports the Results of Multicentre Clinical Study Reinforces the Surgical Utility of the Molteno3 Glaucoma Drainage Device	05/08/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nova Eye Medical Limited

Equities

EYE

AU0000094252

Highlights

Filters